Matritech, Inc.
Records under this name other than patents Matritech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,027,905 | Methods for the detection of cervical cancer Formerly held Term ended Term ended Dec 11, 2017 · From the USPTO record | Term ended | Term ended Dec 11, 2017 | From the USPTO record |
| US 6,803,189 | Methods for the detection of cervical cancer Formerly held Term ended Term ended Aug 30, 2016 · From the USPTO record | Term ended | Term ended Aug 30, 2016 | From the USPTO record |
| US 6,162,608 | Nuclear matrix protein fluid assay Formerly held Lapsed on the fee record Ended Dec 19, 2012 · From the USPTO record | Lapsed on the fee record | Ended Dec 19, 2012 | From the USPTO record |
| US 6,410,247 | Nuclear matrix protein fluid assay Formerly held Term ended Ended no later than Oct 31, 2011 · From the USPTO record | Term ended | Ended no later than Oct 31, 2011 | From the USPTO record |
| US 6,740,494 | Nuclear Matrix Protein Fluid Assay Formerly held Term ended Term ended Oct 31, 2011 · Medium confidence | Term ended | Term ended Oct 31, 2011 | Medium confidence |
| US 6,936,424 | Materials and methods for detection and treatment of breast cancer Formerly held Lapsed on the fee record Ended Aug 30, 2009 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2009 | From the USPTO record |
| US 6,218,131 | Materials and methods for detection of breast cancer Lapsed on the fee record Ended Apr 17, 2005 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2005 | From the USPTO record |
| US 5,547,928 | Methods and compositions for the detection of colon cancers Formerly held Term ended Term ended no later than Aug 20, 2016 · Low confidence | Term ended | Term ended no later than Aug 20, 2016 | Low confidence |
| US 5,686,562 | Malignant cell type markers of the interior nuclear matrix Formerly held Term ended Term ended no later than Nov 11, 2017 · Low confidence | Term ended | Term ended no later than Nov 11, 2017 | Low confidence |
| US 5,698,439 | Novel malignant cell type markers of the interior nuclear matrix Formerly held Term ended Term ended no later than Dec 16, 2017 · Low confidence | Term ended | Term ended no later than Dec 16, 2017 | Low confidence |